Riley Jennifer 4
4 · Avalo Therapeutics, Inc. · Filed Dec 12, 2025
Insider Transaction Report
Form 4
Riley Jennifer
Chief Strategy Officer
Transactions
- Tax Payment
Common Stock
2025-12-10$4.10/sh−637$2,612→ 2,655 total
Footnotes (1)
- [F1]Includes 2,655 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as a part of this reporting transaction.